[Federal Register Volume 67, Number 250 (Monday, December 30, 2002)]
[Notices]
[Page 79637]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-32864]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


National Vaccine Advisory Committee, Subcommittee on Future 
Vaccines, Subcommittee on Immunization Coverage, and Subcommittee on 
Vaccine Safety and Communication Meetings

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following Federal advisory committee 
meetings.

    Name: National Vaccine Advisory Committee (NVAC).
    Times and Dates: 9 a.m.-5 p.m., February 4, 2003; 8:30 a.m.-3 
p.m., February 5, 2003.
    Place: Hubert H. Humphrey Building, Room 705A, 200 Independence 
Avenue, SW., Washington, DC 20201.
    Status: Open to the public, limited only by the space available.
    Notice: In the interest of security, the Department has 
instituted stringent procedures for entrance to the Hubert H. 
Humphrey Building by non-government employees. Thus, persons without 
a government identification card should plan to arrive at the 
building each day either between 8 a.m. and 8:30 a.m. or 12:30 p.m. 
and 1 p.m. Entrance to the meeting at other times during the day 
cannot be assured.
    Purpose: This committee advises and makes recommendations to the 
Director of the National Vaccine Program on matters related to the 
Program responsibilities.
    Matters to be Discussed: Agenda items will include: a report 
from the National Vaccine Program Office (NVPO) and the Interagency 
Vaccine Workgroup; a report from the Assistant Secretary for Health; 
a discussion of homeland security and the role of vaccines; an 
update on the status of the smallpox vaccination program; an update 
on vaccine supply; an update on compensation for vaccine 
administration: Centers for Medicare and Medicaid Services Ruling; a 
report from the NVAC Workgroup on Public Health Options for 
Implementing Immunization Requirements; a report from the Institute 
of Medicine (IOM) regarding SV-40; a discussion of the Department of 
Health and Human Services global health agenda; an update on polio 
eradication and polio laboratory containment; a discussion of the 
Homeland Security Act; reports from the Vaccine Safety and 
Communication Subcommittee, Immunization Coverage Subcommittee, and 
the Future Vaccines Subcommittee; and, reports from the Advisory 
Commission on Childhood Vaccines/Division of Vaccine Injury 
Compensation, Vaccine Related Biological Products Advisory 
Committee/Food and Drug Administration, Advisory Committee on 
Immunization Practices/National Immunization Program/National Center 
for Infectious Diseases.

    Name: Subcommittee on Future Vaccines.
    Time and Date: 3:15 p.m.-5 p.m., February 4, 2003.
    Place: Hubert H. Humphrey Building, Room 405A, 200 Independence 
Avenue, SW., Washington, DC 20201.
    Status: Open to the public, limited only by the space available.
    Purpose: This subcommittee develops policy options and guides 
national activities that lead to accelerated development, licensure, 
and the best use of new vaccines in the simplest possible 
immunization schedules.
    Matters to be Discussed: Agenda items include an update on 
planning for a workshop on Pneumococcal Disease Prevention in 
Adults; discussion of pertussis vaccine strategies; and, a 
discussion of future vaccine technologies.

    Name: Subcommittee on Immunization Coverage.
    Time and Date: 3:15 p.m.-5 p.m., February 4, 2003.
    Place: Hubert H. Humphrey Building, Room 705A, 200 Independence 
Avenue, SW., Washington, DC 20201.
    Status: Open to the public, limited only by the space available.
    Purpose: This subcommittee will identify and propose solutions 
that provide a multifaceted and holistic approach to reducing 
barriers that result in low immunization coverage for children.
    Matters to be Discussed: Agenda items will include an update on 
Publication of Adult and Pediatric Standards; presentation of the 
draft report from the Workgroup on Public Health Options for 
Implementing Immunization Recommendations; an update on the status 
of the IOM report on vaccine financing; a discussion of creative 
methods for funding immunization registries; a review of adolescent 
coverage rates; and, areas of focus for unmet needs funding.

    Name: Subcommittee on Vaccine Safety and Communication.
    Time and Date: 3:15 p.m.-5 p.m., February 4, 2003.
    Place: Hubert H. Humphrey Building, Room 425A, 200 Independence 
Avenue, SW., Washington, DC 20201.
    Status: Open to the public, limited only by the space available.
    Purpose: This subcommittee reviews issues relevant to vaccine 
safety and adverse reactions to vaccines.
    Matters to be Discussed: Items to be discussed include a report 
from the IOM Vaccine Safety Review Committee on future activities 
and risk communication recommendations; a follow-up of the NVPO Risk 
Communication Workshop; and, a discussion of the smallpox vaccine 
communication plan.
    Agenda items are subject to change as priorities dictate.
    Contact Person for More Information: Gloria Sagar, Committee 
Management Specialist, NVPO, CDC, 4700 Buford Highway M/S K-77, 
Chamblee, Georgia 30341, telephone 770/488-2040.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities for both the Centers for Disease Control and Prevention 
and the Agency for Toxic Substances and Disease Registry.

    Dated: December 20, 2002.
Alvin Hall,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention (CDC).
[FR Doc. 02-32864 Filed 12-27-02; 8:45 am]
BILLING CODE 4163-18-P